Recent discussions on the economics of innovation in rapid diagnostic testing for bacterial infections in the hospital setting have inspired me to once again take pen (keyboard) in hand.
Research and breakthroughs at the intersection of biology and medicine — from gene editing and synthetic biology to clinical trials, diagnostics, and the science driving next-generation therapies.
